Dr. Farhan Ali, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 800
Licensed in Texas since 2008, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Tulane University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license M9790 (first issued 2008; active) -
Cardiovascular Disease Physician
TX license M9790 (first issued 2008; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Texas Health Harris Methodist Fort Worth Fort Worth, TX
- Baylor Scott and White All Saints Medical Center Fort Worth, TX
- Medical City Fort Worth Fort Worth, TX
Medical groups
- Heart Center of North Texas PA (16 clinicians)
- Makd Heart and Vascular LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 800
- Services billed
- 4,231
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 669 | 515 |
| Injection, regadenoson, 0.1 mg | 368 | 92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 361 | 350 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | 210 |
| Established patient office or other outpatient visit, 30-39 minutes | 207 | 169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 119 | 99 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 109 | 100 |
| Ultrasound study of arm and leg arteries | 98 | 92 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 95 | 94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 94 | 94 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Fort Worth, TX | 299 |
| Metoprolol Succinate Other prescribers in Fort Worth, TX | 291 |
| Losartan Potassium Other prescribers in Fort Worth, TX | 271 |
| Eliquis (apixaban) Other prescribers in Fort Worth, TX | 252 |
| Amlodipine Besylate Other prescribers in Fort Worth, TX | 216 |
| Atorvastatin Calcium Other prescribers in Fort Worth, TX | 166 |
| Hydrochlorothiazide Other prescribers in Fort Worth, TX | 146 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Fort Worth, TX | 134 |
| Carvedilol Other prescribers in Fort Worth, TX | 115 |
| Hydralazine Hcl Other prescribers in Fort Worth, TX | 108 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 50 payments worth $3,207 in total to this clinician.
| Edwards Lifesciences Corporation | $1,779 |
|---|---|
| Medtronic, Inc. | $526 |
| Shockwave Medical, Inc | $122 |
| Cagent Vascular Inc | $122 |
| Abiomed | $103 |
| Inspire Medical Systems, Inc. | $83.48 |
| Cleerly, Inc. | $75.24 |
| Boston Scientific Corporation | $58.44 |
| Food and Beverage | $2,480 |
|---|---|
| Travel and Lodging | $727 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Edwards Lifesciences Corporation Oct 9, 2025 | Travel and Lodging SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · travel to Austin, TX · in-kind | $407 |
| Edwards Lifesciences Corporation Sep 17, 2025 | Travel and Lodging EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves · travel to Austin, TX · in-kind | $189 |
| Edwards Lifesciences Corporation Oct 10, 2025 | Travel and Lodging SAPIEN 3 Ultra RESILIA · Transcatheter Heart Valves · travel to Austin, TX | $131 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $92,560 in research payments for these studies, mostly to the institutions running them.
- The imperative trial: treatment of acute ischemic stroke with the zoom reperfusion system
Imperative Care, Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.